Revisiting Oral Fluoroquinolone and Multivalent Cation Drug-Drug Interactions: Are They Still Relevant?
- Published in:
- Antibiotics (2079-6382), 2019, v. 8, n. 3, p. 108, doi. 10.3390/antibiotics8030108
- By:
- Publication type:
- Article
Works matching Fluoroquinolones (drug interactions)
Results: 26
1
2
Interactions of Fluoroquinolones with Other Drugs: Mechanisms, Variability, Clinical Significance, and Management.
- Published in:
- Clinical Infectious Diseases, 1992, v. 14, n. 1, p. 272
- By:
- Publication type:
- Article
3
OLANZAPINE AND FLUOROQUINOLONES ANTIBIOTICS: A NONCLINICAL STUDY OF DRUG-DRUG INTERACTIONS DUE TO CYP1A2 INHIBITION.
- Published in:
- Farmacia, 2024, v. 72, n. 5, p. 1092, doi. 10.31925/farmacia.2024.5.11
- By:
- Publication type:
- Article
4
Clinically significant interactions with drugs used in the treatment of tuberculosis.
- Published in:
- 2002
- By:
- Publication type:
- journal article
5
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.
- Published in:
- 2001
- By:
- Publication type:
- journal article
6
Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.
- Published in:
- 2001
- By:
- Publication type:
- journal article
7
Effect of Calcium Supplements on the Oral Bioavailability of Moxifloxacin in Healthy Male Volunteers.
- Published in:
- Clinical Pharmacokinetics, 2001, v. 40, n. 1, p. 27, doi. 10.2165/00003088-200140001-00004
- By:
- Publication type:
- Article
8
Effects of Iron Supplements on the Oral Bioavailability of Moxifloxacin, a Novel 8-Methoxyfluoroquinolone, in Humans.
- Published in:
- Clinical Pharmacokinetics, 2001, v. 40, n. 1, p. 57, doi. 10.2165/00003088-200140001-00008
- By:
- Publication type:
- Article
9
Pharmacokinetics, Safety and Tolerability of Moxifloxacin, a Novel 8-Methoxyfluoroquinolone, after Repeated Oral Administration.
- Published in:
- Clinical Pharmacokinetics, 2001, v. 40, n. 1, p. 1, doi. 10.2165/00003088-200140001-00001
- By:
- Publication type:
- Article
10
Lack of Pharmacokinetic Interaction between Moxifloxacin, a Novel 8-Methoxyfluoroquinolone, and Theophylline.
- Published in:
- Clinical Pharmacokinetics, 2001, v. 40, n. 1, p. 63, doi. 10.2165/00003088-200140001-00009
- By:
- Publication type:
- Article
11
Effect of Cimetidine on the Pharmacokinetics of Oral Gemifloxacin in Healthy Volunteers.
- Published in:
- Clinical Drug Investigation, 2001, v. 21, n. 7, p. 519, doi. 10.2165/00044011-200121070-00008
- By:
- Publication type:
- Article
12
Comparative tolerability of the newer fluoroquinolone antibacterials.
- Published in:
- 1999
- By:
- Publication type:
- journal article
13
Potential Interactions of the Extended-Spectrum Fluoroquinolones with the CNS.
- Published in:
- Drug Safety, 1999, v. 21, n. 2, p. 123, doi. 10.2165/00002018-199921020-00005
- By:
- Publication type:
- Article
14
Influence of Substituents in β-Cyclodextrin on the Interaction of Levofloxacin–β-Cyclodextrin Complexes with Liposomal Membrane.
- Published in:
- Colloid Journal, 2021, v. 83, n. 6, p. 794, doi. 10.1134/S1061933X21060168
- By:
- Publication type:
- Article
15
Inhibitory effect of several fluoroquinolones on hepatic microsomal cytochrome P-450 1A activities in dogs.
- Published in:
- Journal of Veterinary Pharmacology & Therapeutics, 2005, v. 28, n. 6, p. 553, doi. 10.1111/j.1365-2885.2005.00698.x
- By:
- Publication type:
- Article
16
Psychiatric Drugs and Antibiotics. When Two Worlds Collide.
- Published in:
- BRAIN: Broad Research in Artificial Intelligence & Neuroscience, 2019, v. 10, p. 43
- By:
- Publication type:
- Article
17
INTERACTION STUDY OF MOXIFLOXACIN AND LOMEFLOXACIN WITH CO-ADMINISTERED DRUGS.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2011, v. 24, n. 3, p. 339
- By:
- Publication type:
- Article
18
An in silico approach to analyze HCV genotype-specific binding-site variation and its effect on drug–protein interaction.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77720-9
- By:
- Publication type:
- Article
19
A Critical Review of the Fluoroquinolones: Focus on Respiratory Infections.
- Published in:
- Drugs, 2002, v. 62, n. 1, p. 13, doi. 10.2165/00003495-200262010-00002
- By:
- Publication type:
- Article
20
The Role of Fluoroquinolones in Tuberculosis Today.
- Published in:
- Drugs, 2001, v. 61, n. 1, p. 9, doi. 10.2165/00003495-200161010-00002
- By:
- Publication type:
- Article
21
Potential drug interactions with antibacterials in long-term care facilities analyzed by two interaction checkers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
22
Pharmacokinetic interactions related to the chemical structures of fluoroquinolones.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1996, v. 37, n. suppl_A, p. 41, doi. 10.1093/jac/37.suppl_A.41
- By:
- Publication type:
- Article
23
Drug interactions with quinolones.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1990, v. 26, n. suppl_D, p. 7
- By:
- Publication type:
- Article
24
Fluoroquinolones as Tyrosinase Inhibitors; Enzyme Kinetics and Molecular Docking Studies to Explore Their Mechanism of Action.
- Published in:
- Applied Sciences (2076-3417), 2022, v. 12, n. 10, p. 4849, doi. 10.3390/app12104849
- By:
- Publication type:
- Article
25
Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs.
- Published in:
- Journal of Veterinary Internal Medicine, 2016, v. 30, n. 1, p. 108, doi. 10.1111/jvim.13796
- By:
- Publication type:
- Article
26
Elevated gatifloxacin and reduced rifampicin concentrations in a single-dose interaction study amongst healthy volunteers.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2007, v. 60, n. 6, p. 1398, doi. 10.1093/jac/dkm393
- By:
- Publication type:
- Article